Propanc's CEO believes proenzyme therapy may become healthcare solution of choice for cancer. The White House determined to reduce the cost of drugs.

Propanc Biopharma Receives Notice of Allowance for Proenzyme Compositions to Treat Cancer from the European Patent Office. The Second Patent Application Allowed with a Third Under Examination in ...